Labcorp Holdings (LH) Cash from Discontinued Operations (2022 - 2023)

Labcorp Holdings' (LH) quarterly Cash from Discontinued Operations came in at 189900000.0 in Q2 2023, up 394.42% quarter-over-quarter from 64500000.0 in Q1 2023.

Labcorp Holdings (LH) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends

Labcorp Holdings has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting 189900000.0 for Q2 2023.

  • Cash from Discontinued Operations for Q2 2023 came in at 189900000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was 189900000.0 (changed N/A YoY), and the FY2023 annual result was 125400000.0, down 34.38% from the prior year.
  • Cash from Discontinued Operations came in at 189900000.0 for Q2 2023 at Labcorp Holdings, up from 64500000.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 189900000.0 in Q2 2023 to a low of 64500000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn -
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn -
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn -
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn -
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn -
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn -
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn -
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn -
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn -
10 Labcorp Holdings 22.31 Bn 21.34 Bn 1.01 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2023 189.90 Mn
Jun 30, 2023 189.90 Mn
Mar 31, 2023 -64.50 Mn
Mar 31, 2023 -64.50 Mn
Dec 31, 2022 46.40 Mn
Dec 31, 2022 46.40 Mn
Sep 30, 2022 120.80 Mn
Sep 30, 2022 120.80 Mn